TrialNeurology2019
Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability.
Janet H Ford et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled ittrialcites it